Loading...

Zura Bio Limited

94E.FXETRA
Healthcare
Biotechnology
1.20
-0.09(-6.98%)

Zura Bio Limited (94E.F) Company Profile & Overview

Explore Zura Bio Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Zura Bio Limited (94E.F) Company Profile & Overview

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

SectorHealthcare
IndustryBiotechnology
CEORobert Lisicki

Contact Information

858 247 0520
4225 Executive Square, San Diego, CA, 92037

Company Facts

30 Employees
IPO DateMar 21, 2023
CountryUS
Actively Trading

Frequently Asked Questions

;